Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genecopoeia Inc. is a leading biotechnology company specializing in genomics and proteomics research products and services. Founded in 1999, the company provides a wide range of tools for researchers, including gene synthesis, ORF clones, shRNA, CRISPR-Cas9 gene editing tools, viral packaging services, and custom antibody development. Genecopoeia aims to accelerate scientific discovery by offering high-quality, reliable, and innovative solutions to the global life sciences community.
Core R&D, manufacturing of genomic products, global operations management, and customer support.
Situated in the I-270 Technology Corridor, known as 'DNA Alley', surrounded by leading biotech firms and federal research institutions like NIH. Features advanced labs for gene synthesis, viral vector production, and molecular biology.
A science-focused, innovative environment encouraging collaboration, precision, and quality in developing research tools. Emphasis on technical expertise and customer service, fostering a dynamic atmosphere for scientific advancement.
Strategic location for talent acquisition, industry collaboration, and access to the U.S. East Coast biotech market. Key site for product innovation, quality control, and distribution to North American and global customers.
Genecopoeia supports the global life sciences research community through its headquarters in the USA (Rockville, MD) and key international offices in Guangzhou, China, and Bonn, Germany. This strategic network facilitates worldwide manufacturing, distribution, sales, and technical support for its extensive portfolio of genomic and proteomic tools and services. Functions supported globally include gene synthesis, ORF clone production, CRISPR reagent supply, viral vector services, custom antibody development, and comprehensive CRO services, ensuring researchers worldwide have access to their innovative solutions.
9620 Medical Center Drive, Suite 101
Rockville
Maryland
USA
Address: Building C, Suite 408, No.10 Yongda Road, Huangpu District, Guangzhou, 510530
To cater to the growing demand for genomic research tools in China and other Asian countries, offering localized support, custom services, and faster turnaround times for products and services.
Address: Siemenstraße 10, 53121 Bonn
To provide dedicated service and logistical support to the European scientific community, ensuring timely delivery of products and responsive technical assistance for genomic and proteomic research solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, GeneCopoeia' leadership includes:
GeneCopoeia has been backed by several prominent investors over the years, including:
Publicly available information and news searches do not indicate major executive hires or exits at Genecopoeia within the last 12 months. The company appears to maintain a stable leadership team focused on ongoing operations and research & development initiatives.
Discover the tools GeneCopoeia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Genecopoeia commonly utilizes the email format of the first initial followed by the last name. This is a standard convention for many companies in the biotechnology sector, allowing for easy contact with their team members.
flast@genecopoeia.com
Format
rli@genecopoeia.com
Example
80%
Success rate
Genecopoeia Blog • February 1, 2024
Genecopoeia is promoting its advanced CRISPR-Cas9 based knockin services for creating genetically engineered mouse and rat models. These services provide researchers with powerful tools for in vivo gene function studies and disease modeling, enabling precise genetic modifications....more
Genecopoeia Press Release • January 12, 2023
Genecopoeia announced its expanded custom viral particle production services, including AAV, lentivirus, adenovirus, and other viral vectors. These services cater to researchers needing high-quality, ready-to-use viral particles for gene delivery and gene therapy research....more
PR Newswire • May 19, 2020
Genecopoeia, Inc. launched its comprehensive catalog of research tools against SARS-CoV-2, the virus causing COVID-19. The offerings include antibodies, antigen and antibody ELISA kits, as well as genes, ORFs, and cDNAs in various vector systems to support global research efforts....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including GeneCopoeia, are just a search away.